Wenfeng Hua

673 citations
19 papers · 496 indexed · h-index 10
Topics
Cancer-related molecular mechanisms research (5 papers)MicroRNA in disease regulation (4 papers)RNA modifications and cancer (4 papers)
Partner nations
ChinaCanadaMacao

In The Last Decade

Wenfeng Hua

16 papers receiving 492 citations

Peers

Wenfeng Hua
Comparison fields: 5 of 46
  • Molecular Biology 354
  • Cancer Research 238
  • Reproductive Medicine 80
  • Immunology 78
  • Obstetrics and Gynecology 67
Replace Qiuyan Guo with:
Qiuyan Guo China
Ge Lou China
Jolijn W. Groeneweg Netherlands
Cuishan Guo China
Susanne Cahill Ireland
Marta Brunetti Norway
Terri Woo United States
Isabella Syring Germany
Jyothsna Rao Australia
Ahmed El‐Balat Germany
Wenfeng Hua relative to Qiuyan Guo China Qiuyan Guo's profile →
Citations per field
00.5×1.5×1.8×
Qiuyan Guo · 1×
Citations per year

Countries citing papers authored by Wenfeng Hua

Since Specialization
Citations

This map shows the geographic impact of Wenfeng Hua's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenfeng Hua with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenfeng Hua more than expected).

Fields of papers citing papers by Wenfeng Hua

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenfeng Hua. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenfeng Hua. The network helps show where Wenfeng Hua may publish in the future.

Co-authorship network of co-authors of Wenfeng Hua

This figure shows the co-authorship network connecting the top 25 collaborators of Wenfeng Hua. A scholar is included among the top collaborators of Wenfeng Hua based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenfeng Hua. Wenfeng Hua is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
#WorkIndexed citations
1 2
2 0
3 0
4 34
5 1
6 13
7 73
8 9
9 12
10 14
11 5
12 0
13 145
14 6
15 95
16 48
17 10
18 28
19
[Distribution of HCV genotypes in volunteer blood donors in Guangzhou].
1

About Wenfeng Hua

Wenfeng Hua is a scholar working on Reproductive Medicine, Cancer Research and Obstetrics and Gynecology, having authored 19 papers that have together received 496 indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (5 papers), MicroRNA in disease regulation (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Cancer Research (238 citations), Reproductive Medicine (80 citations) and Obstetrics and Gynecology (67 citations). Wenfeng Hua has collaborated with scholars based in China, Canada and Macao. Frequent co-authors include Jing He, Ping Duan, Yuan Zhao, Danyang Yu, Xiaohan Jin, Dan Xie, Xin Huang, Guowei Li, Xuejiao Chen and Yu‐Ming Chen. Their work appears in journals such as International Journal of Cancer, Biology of Reproduction and Gynecologic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026